WOCN Homepage


175

Managing Diarrhea and Fecal Incontinence: Results of a Prospective Clinical Study in the ICU

Anantha Padmanabhan, MD1, Kimberly Howe, Ph.Dc., RN2, Mark A. Stern, MD3, Jeffrey Williams, MD3, Mari Mangino, RN, CRC4, and Eileen McCann, RN, CWOCN5. (1) Colorectal Surgery Associates, Clinical Director, Columbus, OH, (2) Forum Health/Western Reserve Care System, Corporate Director of Research, 500 Gypsy Lane, Youngstown, OH 44504, (3) Atlanta Academic Research Group, Clinician, Decatur, GA 30033, (4) Clinical Nursing Research Coordinator, (5) Ostomy Wound Care Nurse, Stamford, CT 06904

Managing fecal incontinence and diarrhea challenges intensive care unit (ICU) and hospital staff. An innovative fecal management system (F*) uses an inflated balloon to retain a tube within the rectum. An external pouch collects fecal material for patients with uncontrolled diarrhea. This prospective study evaluated safety and performance of F in 42 subjects with diarrhea and incontinence in 7 US hospitals. Endoscopic rectal vault proctoscopies assessed anorectal mucosal condition pre-insertion and post-removal on 8 initial subjects. Investigators reported on ease of F insertion and removal, device retention and leakage, patient comfort, perineal skin condition and odor during use. F performed well with duration of use ranging from 1 to 14 days. The device was generally well-tolerated. Five deaths occurred from non-product-related illnesses and one subject with multi-system organ disease and history of GI bleed had an episode of lower GI bleeding while using the device. Clinicians rated F easy-to-insert (97% of subjects rated), remove (97%) and dispose of (100%) with easy-to-follow instructions (100%). On 200 daily assessments, F was rated as improving fecal incontinence control in 83%, as time efficient in 89% and as efficacious in 86%. Four subjects were unable to retain the device. Clinicians reported no odor on 85% of daily assessments and no or limited leakage on 82%. In this setting of diarrhea and incontinence, perineal and buttock skin condition were maintained/improved in 92% of patients. The device was determined to have an overall favorable safety profile in this study, helping reduce risk of perineal and buttock skin breakdown.

Product notation: *Flexi-SealŪ Fecal Management System, ConvaTec, Princeton, NJ, USA. Flexi-Seal is a registered trademark of E. R. Squibb & Sons, L. L. C.


See more of Practice Innovation Poster Abstracts
See more of Practice Innovation Abstracts

See more of The 38th Annual WOCN Society Conference (June 24 -- 28, 2006)